Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Yuichiro Doki, Jaffer A. Ajani, Ken Kato*, Jianming Xu, Lucjan Wyrwicz, Satoru Motoyama, Takashi Ogata, Hisato Kawakami, Chih Hung Hsu, Antoine Adenis, Farid El Hajbi, Maria Di Bartolomeo, Maria I. Braghiroli, Eva Holtved, Sandra A. Ostoich, Hye R. Kim, Masaki Ueno, Wasat Mansoor, Wen Chi Yang, Tianshu LiuJohn Bridgewater, Tomoki Makino, Ioannis Xynos, Xuan Liu, Ming Lei, Kaoru Kondo, Apurva Patel, Joseph Gricar, Ian Chau, Yuko Kitagawa, CheckMate 648 Trial Investigators

*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

317 Downloads (Pure)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma'. Sammen danner de et unikt fingeraftryk.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology